ME Staff
-
0

Analyst Ratings For Puma Biotechnology (NASDAQ:PBYI)

.

Some recent analyst ratings include

    Recent Insider Trading Activity For Puma Biotechnology (NASDAQ:PBYI)
    Puma Biotechnology (NASDAQ:PBYI) has insider ownership of 21.10% and institutional ownership of 94.53%.

    • On 1/22/2018 Alan H Auerbach, Insider, sold 10,692 with an average share price of $92.75 per share and the total transaction amounting to $991,683.00.
    • On 1/22/2018 Richard Paul Bryce, SVP, sold 1,860 with an average share price of $92.75 per share and the total transaction amounting to $172,515.00.
    • On 12/1/2017 Charles R Eyler, Insider, sold 1,322 with an average share price of $105.46 per share and the total transaction amounting to $139,418.12.
    • On 9/29/2017 Richard Paul Bryce, SVP, sold 15,000 with an average share price of $120.00 per share and the total transaction amounting to $1,800,000.00.
    • On 9/7/2017 Richard Paul Bryce, SVP, sold 15,000 with an average share price of $100.09 per share and the total transaction amounting to $1,501,350.00.
    • On 7/20/2017 Alan H Auerbach, Insider, sold 13,175 with an average share price of $94.73 per share and the total transaction amounting to $1,248,067.75.
    • On 7/20/2017 Richard Paul Bryce, SVP, sold 1,998 with an average share price of $94.48 per share and the total transaction amounting to $188,771.04.

    Recent Trading Activity for Puma Biotechnology (NASDAQ:PBYI)
    Shares of Puma Biotechnology closed the previous trading session at 81.20 up +0.35 0.43% with 83.1500015258789 shares trading hands.